Table of Contents
International Scholarly Research Notices
Volume 2014, Article ID 186207, 7 pages
http://dx.doi.org/10.1155/2014/186207
Research Article

An Efficient and Facile Synthesis of 1,2,4-Aryl Triazoles and 4-Thiazolidinones Bearing 6-Fluorochroman Nucleus

Chemical Research Laboratory, Department of Chemistry, Saurashtra University, Rajkot 360005, India

Received 14 April 2014; Accepted 5 July 2014; Published 30 October 2014

Academic Editor: Xin Wang

Copyright © 2014 Piyush B. Vekariya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Kers, G. Csjernyik, I. MacSari et al., “Structure and activity relationship in the (S)-N-chroman-3-ylcarboxamide series of voltage-gated sodium channel blockers,” Bioorganic and Medicinal Chemistry Letters, vol. 22, no. 17, pp. 5618–5624, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Nishida, H. Yoshinaga, T. Toyoda, and M. Toshima, “First- and second-generation practical syntheses of chroman-4-one derivative: a key intermediate for the preparation of SERT/5-HT1A dual inhibitors,” Organic Process Research and Development, vol. 16, no. 4, pp. 625–634, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Mauler and E. Horváth, “Neuroprotective efficacy of repinotan HCl, a 5-HT1A receptor agonist, in animal models of stroke and traumatic brain injury,” Journal of Cerebral Blood Flow and Metabolism, vol. 25, no. 4, pp. 451–459, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. S. B. Ross, S. Thorberg, E. Jerning et al., “Robalzotan (NAD-299), a novel selective 5-HT(1A) receptor antagonist,” CNS Drug Reviews, vol. 5, no. 3, pp. 213–232, 1999. View at Google Scholar · View at Scopus
  5. T. J. Cleophas, I. Grabowsky, M. G. Niemeyer, W. N. Mäkel, and E. E. van der Wall, “Long-term efficacy of nebivolol monotherapy in patients with hypertension,” Current Therapeutic Research—Clinical and Experimental, vol. 62, no. 6, pp. 451–461, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Shelke, G. Mhaske, S. Gadakh, and C. Gill, “Green synthesis and biological evaluation of some novel azoles as antimicrobial agents,” Bioorganic & Medicinal Chemistry Letters, vol. 20, no. 24, pp. 7200–7204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Sztanke, T. Tuzimski, J. Rzymowska, K. Pasternak, and M. Kandefer-Szerszeń, “Synthesis, determination of the lipophilicity, anticancer and antimicrobial properties of some fused 1,2,4-triazole derivatives,” European Journal of Medicinal Chemistry, vol. 43, no. 2, pp. 404–419, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Alanine, L. Anselm, L. Steward, S. Thomi, W. Vifian, and M. D. Groaning, “Synthesis and SAR evaluation of 1,2,4-triazoles as A2A receptor antagonists,” Bioorganic and Medicinal Chemistry Letters, vol. 14, no. 3, pp. 817–821, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Zamani, K. Faghihi, M. R. Sangi, and J. Zolgharnein, “Synthesis of some new substituted 1,2,4-triazole and 1,3,4-thiadiazole and their derivatives,” Turkish Journal of Chemistry, vol. 27, no. 1, pp. 119–125, 2003. View at Google Scholar · View at Scopus
  10. N. Raghav and M. Singh, “Acyl hydrazides and triazoles as novel inhibitors of mammali an cathepsin B and cathepsin H,” European Journal of Medicinal Chemistry, vol. 77, pp. 231–242, 2014. View at Publisher · View at Google Scholar
  11. S. P. Singh, S. S. Parmar, K. Raman, and V. I. Stenberg, “Chemistry and biological activity of thiazolidinones,” Chemical Reviews, vol. 81, no. 2, pp. 175–203, 1981. View at Publisher · View at Google Scholar · View at Scopus
  12. C. V. Kavitha, Basappa, S. N. Swamy et al., “Synthesis of new bioactive venlafaxine analogs: Novel thiazolidin-4-ones as antimicrobials,” Bioorganic and Medicinal Chemistry, vol. 14, no. 7, pp. 2290–2299, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Kumar, S. Sharma, K. Bajaj et al., “Some new 2,3,6-trisubstituted quinazolinones as potent anti-inflammatory, analgesic and COX-II inhibitors,” Bioorganic and Medicinal Chemistry, vol. 11, no. 23, pp. 5293–5299, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Sharma, T. Singh, R. Mittal, K. K. Saxena, V. K. Srivastava, and A. Kumar, “A study of anti-inflammatory activity of some novel α-amino naphthalene and β-amino naphthalene derivatives,” Archiv der Pharmazie, vol. 339, no. 3, pp. 145–152, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Raja Solomon, W. Haq, K. Srivastava, S. K. Puri, and S. B. Katti, “Synthesis and antimalarial activity of side chain modified 4-aminoquinoline derivatives,” Journal of Medicinal Chemistry, vol. 50, no. 2, pp. 394–398, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Zhou, S. Wu, S. Zhai et al., “Design, synthesis, cytoselective toxicity, structure-activity relationships, and pharmacophore of thiazolidinone derivatives targeting drug-resistant lung cancer cells,” Journal of Medicinal Chemistry, vol. 51, no. 5, pp. 1242–1251, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. R. B. Pathak, P. T. Chovatia, and H. H. Parekh, “Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives,” Bioorganic and Medicinal Chemistry Letters, vol. 22, no. 15, pp. 5129–5133, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. M. L. Barreca, J. Balzarini, A. Chimirri et al., “Design, synthesis, structure - Activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents,” Journal of Medicinal Chemistry, vol. 45, no. 24, pp. 5410–5413, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. R. S. Harisha, K. M. Hosamani, and R. S. Keri, “Synthesis, in-vitro microbial and cytotoxic studies of new benzimidazole derivatives,” Archiv der Pharmazie, vol. 342, no. 7, pp. 412–419, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Cunico, C. R. B. Gomes, M. D. L. G. Ferreira, L. R. Capri, M. Soares, and S. M. S. V. Wardell, “One-pot synthesis of 2-isopropyl-3-benzyl-1,3-thiazolidin-4-ones and 2-phenyl-3-isobutyl-1,3-thiazolidin-4-ones from valine, arenealdehydes and mercaptoacetic acid,” Tetrahedron Letters, vol. 48, no. 35, pp. 6217–6220, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. D. R. St. Laurent, Q. Gao, D. Wu, and M. H. Serrano-Wu, “Regioselective synthesis of 3-(heteroaryl)-iminothiazolidin-4-ones,” Tetrahedron Letters, vol. 45, no. 9, pp. 1907–1910, 2004. View at Publisher · View at Google Scholar · View at Scopus